On 20 June we published final draft guidance recommending cystic fibrosis (CF) treatments Kaftrio, Symkevi and Orkambi following a new commercial deal agreed between NHS England and company Vertex.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results